Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CHEK vs GXAI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CHEK
Check-Cap Ltd.

Medical - Diagnostics & Research

HealthcareNASDAQ • IL
Market Cap$12M
5Y Perf.-37.0%
GXAI
Gaxos.ai Inc.

Electronic Gaming & Multimedia

TechnologyNASDAQ • US
Market Cap$2M
5Y Perf.-95.8%

CHEK vs GXAI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CHEK logoCHEK
GXAI logoGXAI
IndustryMedical - Diagnostics & ResearchElectronic Gaming & Multimedia
Market Cap$12M$2M
Revenue (TTM)$0.00$694K
Net Income (TTM)$-25M$-4M
Gross Margin79.2%
Operating Margin-6.6%
Total Debt$136K$0.00
Cash & Equiv.$14M

CHEK vs GXAILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CHEK
GXAI
StockFeb 23Jan 26Return
Check-Cap Ltd. (CHEK)10063.0-37.0%
Gaxos.ai Inc. (GXAI)1004.2-95.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CHEK vs GXAI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GXAI leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Check-Cap Ltd. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CHEK
Check-Cap Ltd.
The Quality Compounder

CHEK is the clearest fit if your priority is quality and momentum.

  • 212.2% margin vs GXAI's -5.4%
  • +112.2% vs GXAI's +7.0%
Best for: quality and momentum
GXAI
Gaxos.ai Inc.
The Income Pick

GXAI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.53
  • Rev growth 14.7%, EPS growth 52.0%
  • -97.5% 10Y total return vs CHEK's -99.7%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthGXAI logoGXAI14.7% revenue growth vs CHEK's -48.5%
Quality / MarginsCHEK logoCHEK212.2% margin vs GXAI's -5.4%
Stability / SafetyGXAI logoGXAIBeta 0.53 vs CHEK's 0.67
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)CHEK logoCHEK+112.2% vs GXAI's +7.0%
Efficiency (ROA)GXAI logoGXAI-26.4% ROA vs CHEK's -66.7%, ROIC -120.1% vs -287.7%

CHEK vs GXAI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGXAILAGGINGCHEK

Income & Cash Flow (Last 12 Months)

GXAI leads this category, winning 1 of 1 comparable metric.

GXAI and CHEK operate at a comparable scale, with $694,278 and $0 in trailing revenue.

MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
RevenueTrailing 12 months$0$694,278
EBITDAEarnings before interest/tax-$26M-$4M
Net IncomeAfter-tax profit-$25M-$4M
Free Cash FlowCash after capex-$8,004-$4M
Gross MarginGross profit ÷ Revenue+79.2%
Operating MarginEBIT ÷ Revenue-6.6%
Net MarginNet income ÷ Revenue-5.4%
FCF MarginFCF ÷ Revenue-6.4%
Rev. Growth (YoY)Latest quarter vs prior year+183.3%
EPS Growth (YoY)Latest quarter vs prior year-155.6%+77.0%
GXAI leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

GXAI leads this category, winning 1 of 1 comparable metric.
MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
Market CapShares × price$12M$2M
Enterprise ValueMkt cap + debt − cash$12M-$12M
Trailing P/EPrice ÷ TTM EPS-0.48x-0.64x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue538.49x
Price / BookPrice ÷ Book value/share0.13x
Price / FCFMarket cap ÷ FCF
GXAI leads this category, winning 1 of 1 comparable metric.

Profitability & Efficiency

GXAI leads this category, winning 7 of 7 comparable metrics.

GXAI delivers a -27.3% return on equity — every $100 of shareholder capital generates $-27 in annual profit, vs $-2 for CHEK. On the Piotroski fundamental quality scale (0–9), GXAI scores 4/9 vs CHEK's 2/9, reflecting mixed financial health.

MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
ROE (TTM)Return on equity-2.3%-27.3%
ROA (TTM)Return on assets-66.7%-26.4%
ROICReturn on invested capital-2.9%-120.1%
ROCEReturn on capital employed-2.3%-36.9%
Piotroski ScoreFundamental quality 0–924
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash$136,000-$14M
Cash & Equiv.Liquid assets$14M
Total DebtShort + long-term debt$136,000$0
Interest CoverageEBIT ÷ Interest expense-2883.22x
GXAI leads this category, winning 7 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CHEK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CHEK five years ago would be worth $703 today (with dividends reinvested), compared to $251 for GXAI. Over the past 12 months, CHEK leads with a +112.2% total return vs GXAI's +7.0%. The 3-year compound annual growth rate (CAGR) favors CHEK at 14.1% vs GXAI's -52.4% — a key indicator of consistent wealth creation.

MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
YTD ReturnYear-to-date+21.3%+5.2%
1-Year ReturnPast 12 months+112.2%+7.0%
3-Year ReturnCumulative with dividends+48.6%-89.2%
5-Year ReturnCumulative with dividends-93.0%-97.5%
10-Year ReturnCumulative with dividends-99.7%-97.5%
CAGR (3Y)Annualised 3-year return+14.1%-52.4%
CHEK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CHEK and GXAI each lead in 1 of 2 comparable metrics.

GXAI is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CHEK's 0.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHEK currently trades 53.1% from its 52-week high vs GXAI's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
Beta (5Y)Sensitivity to S&P 5000.67x0.53x
52-Week HighHighest price in past year$3.92$2.96
52-Week LowLowest price in past year$0.59$1.02
% of 52W HighCurrent price vs 52-week peak+53.1%+41.2%
RSI (14)Momentum oscillator 0–10058.545.2
Avg Volume (50D)Average daily shares traded2.5M5.9M
Evenly matched — CHEK and GXAI each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricCHEK logoCHEKCheck-Cap Ltd.GXAI logoGXAIGaxos.ai Inc.
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.9%
Insufficient data to determine a leader in this category.
Key Takeaway

GXAI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CHEK leads in 1 (Total Returns). 1 tied.

Best OverallGaxos.ai Inc. (GXAI)Leads 3 of 6 categories
Loading custom metrics...

CHEK vs GXAI: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Which is the better long-term investment — CHEK or GXAI?

Over the past 5 years, Check-Cap Ltd.

(CHEK) delivered a total return of -93. 0%, compared to -97. 5% for Gaxos. ai Inc. (GXAI). Over 10 years, the gap is even starker: GXAI returned -97. 5% versus CHEK's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

02

Which is safer — CHEK or GXAI?

By beta (market sensitivity over 5 years), Gaxos.

ai Inc. (GXAI) is the lower-risk stock at 0. 53β versus Check-Cap Ltd. 's 0. 67β — meaning CHEK is approximately 27% more volatile than GXAI relative to the S&P 500.

03

Which is growing faster — CHEK or GXAI?

On earnings-per-share growth, the picture is similar: Gaxos.

ai Inc. grew EPS 52. 0% year-over-year, compared to -43. 3% for Check-Cap Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

04

Which has better profit margins — CHEK or GXAI?

Check-Cap Ltd.

(CHEK) is the more profitable company, earning 0. 0% net margin versus -850. 3% for Gaxos. ai Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHEK leads at 0. 0% versus -919. 7% for GXAI. At the gross margin level — before operating expenses — GXAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — CHEK or GXAI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

06

Is CHEK or GXAI better for a retirement portfolio?

For long-horizon retirement investors, Gaxos.

ai Inc. (GXAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Both have compounded well over 10 years (GXAI: -97. 5%, CHEK: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between CHEK and GXAI?

These companies operate in different sectors (CHEK (Healthcare) and GXAI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CHEK is a small-cap quality compounder stock; GXAI is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CHEK

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

GXAI

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 9163%
  • Gross Margin > 47%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.